Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia
Clinical trial NCT03891862 · COMPLETED
Trial details
- NCT number
- NCT03891862
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-18
- Primary completion
- 2019-12-23
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.